0.8 ML adalimumab-afzb 50 MG/ML Prefilled Syringe [Abrilada]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.8 ML adalimumab-afzb 50 MG/ML Prefilled Syringe [Abrilada]

50 MG/ML · Prefilled Syringe · injection

A form of adalimumab-afzb →

0.8 ML adalimumab-afzb 50 MG/ML Prefilled Syringe [Abrilada] — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.

0.8 ML adalimumab-afzb 50 MG/ML Prefilled Syringe [Abrilada]

Active ingredient

adalimumab-afzb →

Classification

Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker

Drug interactions

Adalimumab-afzb has several drug interactions that may increase the risk of serious infections or require monitoring of concomitant medications.

  • majorabatacept — Increased risk of serious infection.
  • majoranakinra — Increased risk of serious infection.
  • majorlive vaccines — Avoid use with ABRILADA.
  • moderateCYP450 substrates with a narrow therapeutic index (e.g., warfarin, cyclosporine, theophylline) — Monitoring of the effect or drug concentration is recommended.

Real-world adverse events (FAERS)

Off Label Use833Condition Aggravated616Drug Ineffective335Fatigue255Arthralgia216Pain194Injection Site Pain167Nausea134

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →